Heartcore Capital

Dynamk Capital is an early stage Life Sciences investor and partner that looks to accelerate the growth and adoption of disruptive solutions and services. We are committed to advancing novel technologies for human health. We are passionate about creating the future of biotech and life sciences. We believe innovative services, tools and technologies are critical to enabling the discovery, development and production of life-saving therapies, delivering lower costs, and increasing access to medicines globally. Life science entrepreneurs with highly disruptive, market-defining ideas have long struggled to secure the right mix of capital and expertise. Dynamk addresses this gap with deep domain and technical expertise, coupled with the strategic and commercialization experience to help these companies realize full potential.

Andreessen Horowitz is an investment manager investing in technology companies from seed through growth stage across AI, bio and healthcare, consumer, crypto, enterprise, fintech, games, infrastructure and American dynamism.

Union Square Ventures is a small collegial partnership based in New York that manages over $1B across seven technology-focused venture funds. Union Square Ventures is one of the most successful venture funds in the world and has been an early-stage investor in some of America's most successful startups such as Zynga, Indeed, Tumblr, Twitter, Lending Club, Etsy, Twilio and MongoDB. USV was founded in 2003 by Fred Wilson and Brad Burnham.

GV is an independent venture capital firm launched as Google Ventures in 2009, with Alphabet as its sole limited partner. It invests from seed to growth in technology and life sciences and provides operating-partner support to founding teams.

Eight Roads is a Fidelity-backed global investment platform with venture teams investing in technology and healthcare companies across Asia, Europe, Israel and the US.

Bain Capital Ventures is a venture capital fund focused on high-growth enterprise software opportunities, including SaaS, data services, marketing-tech, fin-tech, healthcare and software. We partner with great B2B founders and accelerate their market vision. Our investments span $1 million seed capital through to $100m growth equity cheques. We draw on a global network of experience, and the full resources of Bain Capital, one of the world's leading alternative asset firms with more than $60 billion under management across a variety of investment strategies. Our focus areas currently include business applications (DocuSign, SendGrid, Gainsight), infrastructure and security (Redis Labs, Rubrik, Armis), financial technology (Acorns, IEX), healthcare IT (AbleTo, ABILITY Network), and consumer (Rent the Runway, Jet). We also have emerging practices in autonomy/mobility (Ike, Lime) and cryptocurrency (DCG, Compound Labs). Bain Capital Ventures invests globally, although the majority of our investments are in the United States